Alterations of hepatic metabolism are critical to the development of liver disease. The
peroxisome proliferator-activated receptor-γ coactivators (PGC1s) are able to orchestrate, on …

Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat accumulates in
the liver of a patient without a history of alcohol abuse. Nonalcoholic steatohepatitis (NASH) …

With the obesity epidemic, nonalcoholic fatty liver disease (NAFLD) has become a public
health problem with increasing prevalence. The mechanism of disease progression remains …

Nonalcoholic fatty liver disease (NAFLD) is increasing in prevalence in concert with the
global epidemic of obesity and is being diagnosed at increasingly younger ages. The …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the United States. Childhood NAFLD is associated with hepatic and non-hepatic morbidity …

BACKGROUND: Perfluorooctane sulfonate (PFOS) was produced by various industries and
was widely used in diverse consumer products. Human sample analysis indicated PFOS …

With the epidemic of childhood obesity, nonalcoholic fatty liver disease (NAFLD) has
become the most common cause of chronic liver disease in pediatrics. NAFLD is strongly …

The characteristics of nonalcoholic fatty liver disease (NAFLD) in elderly patients are
unknown. Therefore, we aimed to examine the differences between elderly and nonelderly …

Currently, Non-Alcoholic Fatty Liver Disease (NAFLD) is the most prevalent form of chronic
liver disease in children and adolescents worldwide. Simultaneously to the epidemic …

The liver is generally considered as a relatively homogeneous organ containing four
different cell types. It is however well-known that the liver is not homogeneous and consists …